Niagen Bioscience says Niagen IV available in more than 1,700 clinics nationwide
NAGE•Niagen Bioscience said Niagen IV is available in more than 1,700 clinics nationwide and is targeting an estimated $500 million NAD+ infusion and injection market through its Niagen Plus portfolio.
1. Products and expansion
Niagen Bioscience said a ready-to-inject liquid Niagen product is available through a clinician-directed telehealth platform under Niagen Plus. The company said its expansion plans include partnerships with large skincare companies and development of therapies for rare genetic diseases.
